Constructing longitudinal disease progression curves using sparse, short‐term individual data with an application to Alzheimer's disease
暂无分享,去创建一个
C A Budgeon | K Murray | B A Turlach | S Baker | V L Villemagne | S C Burnham | B. Turlach | S. Burnham | V. Villemagne | C. Budgeon | S. Baker | K. Murray
[1] Ana Ivelisse Avilés,et al. Linear Mixed Models for Longitudinal Data , 2001, Technometrics.
[2] M. Prince,et al. World Alzheimer Report 2015 - The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends , 2015 .
[3] Harvey Goldstein,et al. Handbook of multilevel analysis , 2008 .
[4] J. Morris,et al. Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans , 2010, Alzheimer's & Dementia.
[5] P. Gottschalk,et al. The five-parameter logistic: a characterization and comparison with the four-parameter logistic. , 2005, Analytical biochemistry.
[6] C. Jack,et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.
[7] C. Jack,et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.
[8] C. Rowe,et al. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease , 2009, International Psychogeriatrics.
[9] The Neuropathology of Alzheimer’s Disease , 2019, Alzheimer’s Disease.
[10] Mark E. Schmidt,et al. The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception , 2012, Alzheimer's & Dementia.
[11] Colin L Masters,et al. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics , 2006, Journal of neurochemistry.
[12] Peter J Gianaros,et al. Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study , 2015, The Lancet Neurology.
[13] Bootstrapping Robust Estimates for Clustered Data , 2010 .
[14] Samuel Müller,et al. Fast and flexible methods for monotone polynomial fitting , 2016 .
[15] G. B. Frisoni,et al. The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort , 2010, Neurobiology of Aging.
[16] C. Masters,et al. Neurodegenerative Diseases: The neuropathology of Alzheimer's disease in the year 2005 , 2005 .
[17] M. Mintun,et al. Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects , 2012, The Journal of Nuclear Medicine.
[18] M. Kenward,et al. An Introduction to the Bootstrap , 2007 .
[19] Nick C Fox,et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.
[20] France Mentré,et al. A comparison of bootstrap approaches for estimating uncertainty of parameters in linear mixed‐effects models , 2013, Pharmaceutical statistics.
[21] G. Molenberghs. Applied Longitudinal Analysis , 2005 .
[22] Matthew L Senjem,et al. Shapes of the trajectories of 5 major biomarkers of Alzheimer disease. , 2012, Archives of neurology.
[23] Robert Chambers,et al. A Random Effect Block Bootstrap for Clustered Data , 2013 .
[24] C. Field,et al. Bootstrapping clustered data , 2007 .
[25] Rudi Verbeeck,et al. Quantifying the pathophysiological timeline of Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[26] V. Narayan,et al. Disease progression model for Clinical Dementia Rating–Sum of Boxes in mild cognitive impairment and Alzheimer’s subjects from the Alzheimer’s Disease Neuroimaging Initiative , 2014, Neuropsychiatric disease and treatment.
[27] M. Weiner,et al. The dynamics of cortical and hippocampal atrophy in Alzheimer disease. , 2011, Archives of neurology.
[28] M. Sherman,et al. A comparison between bootstrap methods and generalized estimating equations for correlated outcomes in generalized linear models , 1997 .
[29] S. Leurgans,et al. Sigmoidal mixed models for longitudinal data , 2018, Statistical methods in medical research.
[30] D. Selkoe. Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.
[31] Mark E. Schmidt,et al. The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception , 2012, Alzheimer's & Dementia.
[32] P. Scheltens,et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.
[33] Keith A. Johnson,et al. Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression. , 2015, Brain : a journal of neurology.
[34] C. Rowe,et al. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study , 2013, The Lancet Neurology.
[35] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[36] Louis Brickman. On Nonnegative Polynomials , 1962 .